SCHEDULE: Point72 Discloses 6.2% Stake in AngioDynamics

Point72 Asset Management, along with its affiliates and Steven A. Cohen, has disclosed a 6.2% beneficial ownership stake in AngioDynamics Inc., totaling 2,559,389 shares.

Summary

• Point72 Asset Management, L.P., Point72 Capital Advisors, Inc., and Steven A. Cohen collectively reported beneficial ownership of 2,559,389 shares of AngioDynamics Inc. common stock.
• This aggregate amount represents 6.2% of AngioDynamics Inc.'s outstanding common stock.
• The shares are held by Point72 Associates, LLC, an investment fund managed by Point72 Asset Management.
• Point72 Capital Advisors Inc. is the general partner of Point72 Asset Management, and Steven A. Cohen controls both entities.
• The reporting persons share both voting and dispositive power over all 2,559,389 shares.
• The securities were not acquired and are not held for the purpose of changing or influencing the control of AngioDynamics Inc., other than activities solely in connection with a nomination under §§ 240.14a-11.

Sentiment

Score: 7

Explanation: The disclosure of a significant stake by a major institutional investor like Point72 Asset Management is generally viewed positively, indicating confidence and potential for increased liquidity or investor interest in AngioDynamics Inc.

Positives

• A significant stake by a prominent institutional investor like Point72 Asset Management can signal confidence in AngioDynamics Inc.'s future prospects.
• The disclosure indicates a substantial institutional interest in the company's common stock.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders may view the significant institutional investment as a positive signal, potentially increasing investor confidence and demand for AngioDynamics Inc. stock.
• The explicit statement that the shares are not held for control purposes suggests a passive investment, which may reassure existing management and board.

Key Dates

Keywords

AngioDynamics, Point72 Asset Management, Steven A. Cohen, Beneficial Ownership, Institutional Investor, SEC Filing, Common Stock, Medical Devices